1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical activity
    Meeting Abstract

    Sosman, J. A.; Kittaneh, M.; Lolkema, Mpjk; Postow, M. A.; Schwartz, G.; Franklin, C.; Matano, A.; Bhansali, S.; Parasuraman, S.; Kim, K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma (UC) based on the impact of prognostic factors
    Meeting Abstract

    Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Early predictors of prolonged overall survival (OS) in patients (pts) on first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): An ARCAD study with individual patient data (IPD) on 10,962 pts
    Meeting Abstract

    Sommeijer, D. W.; Shi, Q.; Saad, E. D.; Coart, E.; Buyse, M. E.; Burzykowski, T.; Meyers, J. P.; Maughan, T.; Adams, R. A.; Seymour, M. T.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Combined KIT and CTLA-4 blockade in patients with refractory GIST and other advanced sarcomas
    Meeting Abstract

    Shoushtari, A. N.; D'Angelo, S. P.; Keohan, M. L.; Dickson, M. A.; Gounder, M. M.; Abdullah, A. K.; Erinjeri, J. P.; Bluth, M. J.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT)
    Meeting Abstract

    Shoushtari, A. N.; Qin, L. X.; Kuk, D.; Magnan, H. D.; Modak, S.; Wolden, S. L.; Cho, E. J.; Pallos, V.; Grubman, O.; Viny, A. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Preliminary data from a multi-arm expansion study of MEDI4736, an anti-PD-L1 antibody
    Meeting Abstract

    Segal, N. H.; Antonia, S. J.; Brahmer, J. R.; Maio, M.; Blake-Haskins, A.; Li, X.; Vasselli, J.; Ibrahim, R. A.; Lutzky, J.; Khieif, S.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1 study of PF-05082566 (anti-4-1BB) in patients with advanced cancer
    Meeting Abstract

    Segal, N. H.; Gopal, A. K.; Bhatia, S.; Kohrt, H. E.; Levy, R.; Pishvalan, M. J.; Houot, R.; Bartlett, N.; Nghlem, P.; Kronenberg, S. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I dose escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) in combination with nivolumab (anti-PD-1; BMS-936558, ONO-4538) in advanced solid tumors
    Meeting Abstract

    Segal, N. H.; Hodi, F. S.; Sanborn, R. E.; Gajewski, T.; Wolchok, J. D.; Urba, W. J.; Fox, B. A.; Topallan, S. L.; Pardoll, D. M.; Kollia, G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Enzalutamide plus exemestane: A pilot study to assess safety, pharmacokinetics, and effects on circulating estrogens in women with advanced hormone-positive breast cancer
    Meeting Abstract

    Schwartzberg, L. S.; Yardley, D. A.; Elias, A. D.; Patel, M. R.; Gucalp, A.; Burris, H. A.; Peterson, A. C.; Hannah, A. L.; Blaney, M. E.; Gibbons, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save